Ginsenosides in vascular remodeling: Cellular and molecular mechanisms of their therapeutic action

Guang-Xuan Zhu,Jian-Li Zuo,Lin Xu,Shu-Qing Li,Guang-Xuan Zhu,Jian-Li Zuo,Lin Xu,Shu-Qing Li

DOI: https://doi.org/10.1016/j.phrs.2021.105647

IF: 10.334

2021-07-01

Pharmacological Research

Abstract:<p>Evidence is mounting that abnormal vascular remodeling (VR) is a vital pathological event that precedes many cardiovascular diseases (CVD). This provides us with a new research perspective that VR can be a pivotal target for CVD treatment and prevention. However, the current drugs for treating CVD do not fundamentally reverse VR and repair vascular function. The reason may be that a complicated regulatory network is formed between the various signaling pathways involved in VR. Recently, ginsenoside, the main active substance of ginseng, has become increasingly the focus of many researchers for its multiple targets, multiple pathways, and few side effects. Several data have revealed that ginsenosides can improve VR caused by vasodilation dysfunction, abnormal vascular structure and blood pressure. This review is intended to discuss the therapeutic effects and mechanisms of ginsenosides in some diseases involved in VR. Besides, we herein also give a new and contradictory insight into intracellular and molecular signaling of ginsenosides in all kinds of vascular cells. Most importantly, we also discuss the feasibility of ginsenosides Rb1/Rg1/Rg3 in drug development by combining the pharmacodynamics and pharmacokinetics of ginsenosides, and provide a pharmacological basis for the development of ginsenosides in clinical applications.</p>

pharmacology & pharmacy